Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

2(25.0%)

8Total

N/A(6)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05403944Not ApplicableActive Not Recruiting

Strength or Power Training for Patellofemoral Pain

Role: collaborator

NCT02236364Terminated

Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye

Role: collaborator

NCT00465452Phase 3Completed

Impact of Switching to Continuous Release Dopamine Agonists

Role: lead

NCT05415436Phase 3Completed

Analyzing the Relationship Between Speed Propofol is Given and Low Blood Pressure

Role: lead

NCT04626310Not ApplicableCompleted

Mapping Aspects of Psychotherapy in Dialectical Behavior Therapy

Role: collaborator

NCT04160182Not ApplicableWithdrawn

Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors

Role: collaborator

NCT05307510Not ApplicableCompleted

Influence of Custom Orthosis Post Carpometacarpal (CMC) Arthroplasty

Role: lead

NCT06309160Not ApplicableRecruiting

COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD

Role: collaborator

NCT05738200Not ApplicableCompleted

Nordic Hamstring Exercise After ACL Reconstruction Reconstruction

Role: lead

All 9 trials loaded